October 3rd 2024
Alert: Oxbryta, rosuvastatin
Pfizer Limited is recalling all distributed batches of Oxbryta 500mg tablets due to risk of fatality. Indicated for the treatment of haemolytic anaemia due to sickle cell disease (SCD) in adults and paediatric patients aged 12 years of age and older,